Australia markets closed

GSK May 2023 38.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.50000.0000 (0.00%)
As of 11:14AM EST. Market open.
Full screen
Previous close3.5000
Open3.5000
Bid0.0000
Ask0.0000
Strike38.00
Expiry date2023-05-19
Day's range3.5000 - 3.5000
Contract rangeN/A
Volume15
Open interest32
  • Zacks

    GSK (GSK) Q4 Earnings and Revenues Top Estimates

    Glaxo (GSK) delivered earnings and revenue surprises of 8.47% and 4.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Yahoo Finance UK

    FTSE 100: GSK tops forecasts after strong sales of shingles vaccine

    GlaxoSmithKline has improved their forecasts for 2023 after results reveal strong sales of the pharmaceutical firm's shingles vaccine.

  • Bloomberg

    Advil Maker Haleon Said to Study Potential Deals to Bulk Up

    (Bloomberg) -- Haleon Plc, the consumer health business spun out from British pharmaceutical producer GSK Plc, is in the early stages of studying large potential deals to bulk up its brand portfolio, people with knowledge of the matter said. Most Read from BloombergSony Slashes PlayStation VR2 Headset Output After Pre-Orders DisappointPutin’s War in Ukraine Pushes Ex-Soviet States Toward New AlliesBrexit Is Costing the UK £100 Billion a Year in Lost OutputTrump Sues Journalist Bob Woodward for R